MIRA Analysis of RARβ2 Gene Methylation in DNA Circulating in the Blood in Lung Cancer

Analysis of DNA epigenetic mutations in the blood circulating DNA is a prospective trend for creation of noninvasive methods for the diagnosis and treatment effi ciency monitoring in cancer. The methylation status of target genes in circulating DNA was evaluated by methods based on preliminary bisul...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bulletin of experimental biology and medicine 2014-08, Vol.157 (4), p.516-519
Hauptverfasser: Kapitskaya, K. Yu, Azhikina, T. L., Ponomaryova, A. A., Cherdyntseva, N. V., Vlasov, V. V., Laktionov, P. P., Rykova, E. Yu
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 519
container_issue 4
container_start_page 516
container_title Bulletin of experimental biology and medicine
container_volume 157
creator Kapitskaya, K. Yu
Azhikina, T. L.
Ponomaryova, A. A.
Cherdyntseva, N. V.
Vlasov, V. V.
Laktionov, P. P.
Rykova, E. Yu
description Analysis of DNA epigenetic mutations in the blood circulating DNA is a prospective trend for creation of noninvasive methods for the diagnosis and treatment effi ciency monitoring in cancer. The methylation status of target genes in circulating DNA was evaluated by methods based on preliminary bisulfi te conversion of DNA. We used a different approach based on selection of hypermethylated sequences of circulating DNA by means of DNA-methyl-binding protein (methylated CpG island recovery assay, MIRA). Methylation was evaluated for RARβ2 tumor suppression gene in circulating DNA in lung cancer and a trend was detected to higher methylation of this gene in the patients in comparison with healthy donors.
doi_str_mv 10.1007/s10517-014-2604-z
format Article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_1554469294</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A386000662</galeid><sourcerecordid>A386000662</sourcerecordid><originalsourceid>FETCH-LOGICAL-c427z-703ad59d5d76967c2736ec1844e50f3f6917ac9a9b0c37f4a762e3f005b01ee63</originalsourceid><addsrcrecordid>eNp9kd9qFDEYxYNY7Fp9AG8kIIg3U5NM_sxcjqvWwlZhUbwM2cw3u1OySU1mLnYfywfxmcwwbWlBJBfhO_mdA_kOQq8oOaeEqPeJEkFVQSgvmCS8OD5BCypUWVSM0adoQTJU8KqqTtHzlK6nkUj6DJ0yQXNALRfo59XlusGNN-6Q-oRDh9fN-s9vhi_AA76CYXdwZuiDx73HH782eNlHO06S307SsAP8wYXQTsNqzOLSeAvxBTrpjEvw8vY-Qz8-f_q-_FKsvl1cLptVYTlTx0KR0rSibkWrZC2VZaqUYGnFOQjSlZ2sqTK2NvWG2FJ13CjJoOwIERtCAWR5ht7NuTcx_BohDXrfJwvOGQ9hTJoKwbmsWc0z-mZGt8aB7n0XhmjshOumrGTejpQsU-f_oPJpYd_b4KHrs_7I8PaBYQfGDbsU3DgtLT0G6QzaGFKK0Omb2O9NPGhK9NSnnvvUuU899amP2fP69nvjZg_tveOuwAywGUj5yW8h6uswxlxn-k_qX71JpsA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1554469294</pqid></control><display><type>article</type><title>MIRA Analysis of RARβ2 Gene Methylation in DNA Circulating in the Blood in Lung Cancer</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Kapitskaya, K. Yu ; Azhikina, T. L. ; Ponomaryova, A. A. ; Cherdyntseva, N. V. ; Vlasov, V. V. ; Laktionov, P. P. ; Rykova, E. Yu</creator><creatorcontrib>Kapitskaya, K. Yu ; Azhikina, T. L. ; Ponomaryova, A. A. ; Cherdyntseva, N. V. ; Vlasov, V. V. ; Laktionov, P. P. ; Rykova, E. Yu</creatorcontrib><description>Analysis of DNA epigenetic mutations in the blood circulating DNA is a prospective trend for creation of noninvasive methods for the diagnosis and treatment effi ciency monitoring in cancer. The methylation status of target genes in circulating DNA was evaluated by methods based on preliminary bisulfi te conversion of DNA. We used a different approach based on selection of hypermethylated sequences of circulating DNA by means of DNA-methyl-binding protein (methylated CpG island recovery assay, MIRA). Methylation was evaluated for RARβ2 tumor suppression gene in circulating DNA in lung cancer and a trend was detected to higher methylation of this gene in the patients in comparison with healthy donors.</description><identifier>ISSN: 0007-4888</identifier><identifier>EISSN: 1573-8221</identifier><identifier>DOI: 10.1007/s10517-014-2604-z</identifier><identifier>PMID: 25110096</identifier><language>eng</language><publisher>Boston: Springer US</publisher><subject>Aged ; Biological Assay ; Biomarkers, Tumor - blood ; Biomarkers, Tumor - genetics ; Biomedical and Life Sciences ; Biomedicine ; Cancer ; Carcinoma, Non-Small-Cell Lung - blood ; Carcinoma, Non-Small-Cell Lung - diagnosis ; Carcinoma, Non-Small-Cell Lung - genetics ; Carcinoma, Non-Small-Cell Lung - pathology ; Care and treatment ; Case-Control Studies ; Cell Biology ; CpG Islands ; DNA ; DNA Methylation ; DNA, Neoplasm - blood ; DNA, Neoplasm - genetics ; Epigenesis, Genetic ; Epigenetic inheritance ; Female ; Genes ; Genetic aspects ; Humans ; Internal Medicine ; Laboratory Medicine ; Lung cancer ; Lung Neoplasms - blood ; Lung Neoplasms - diagnosis ; Lung Neoplasms - genetics ; Lung Neoplasms - pathology ; Male ; Methylation ; Middle Aged ; Pathology ; Protein binding ; Receptors, Retinoic Acid - blood ; Receptors, Retinoic Acid - genetics ; Sulfites ; Sulfites - chemistry</subject><ispartof>Bulletin of experimental biology and medicine, 2014-08, Vol.157 (4), p.516-519</ispartof><rights>Springer Science+Business Media New York 2014</rights><rights>COPYRIGHT 2014 Springer</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c427z-703ad59d5d76967c2736ec1844e50f3f6917ac9a9b0c37f4a762e3f005b01ee63</citedby><cites>FETCH-LOGICAL-c427z-703ad59d5d76967c2736ec1844e50f3f6917ac9a9b0c37f4a762e3f005b01ee63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s10517-014-2604-z$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s10517-014-2604-z$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27922,27923,41486,42555,51317</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25110096$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kapitskaya, K. Yu</creatorcontrib><creatorcontrib>Azhikina, T. L.</creatorcontrib><creatorcontrib>Ponomaryova, A. A.</creatorcontrib><creatorcontrib>Cherdyntseva, N. V.</creatorcontrib><creatorcontrib>Vlasov, V. V.</creatorcontrib><creatorcontrib>Laktionov, P. P.</creatorcontrib><creatorcontrib>Rykova, E. Yu</creatorcontrib><title>MIRA Analysis of RARβ2 Gene Methylation in DNA Circulating in the Blood in Lung Cancer</title><title>Bulletin of experimental biology and medicine</title><addtitle>Bull Exp Biol Med</addtitle><addtitle>Bull Exp Biol Med</addtitle><description>Analysis of DNA epigenetic mutations in the blood circulating DNA is a prospective trend for creation of noninvasive methods for the diagnosis and treatment effi ciency monitoring in cancer. The methylation status of target genes in circulating DNA was evaluated by methods based on preliminary bisulfi te conversion of DNA. We used a different approach based on selection of hypermethylated sequences of circulating DNA by means of DNA-methyl-binding protein (methylated CpG island recovery assay, MIRA). Methylation was evaluated for RARβ2 tumor suppression gene in circulating DNA in lung cancer and a trend was detected to higher methylation of this gene in the patients in comparison with healthy donors.</description><subject>Aged</subject><subject>Biological Assay</subject><subject>Biomarkers, Tumor - blood</subject><subject>Biomarkers, Tumor - genetics</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Cancer</subject><subject>Carcinoma, Non-Small-Cell Lung - blood</subject><subject>Carcinoma, Non-Small-Cell Lung - diagnosis</subject><subject>Carcinoma, Non-Small-Cell Lung - genetics</subject><subject>Carcinoma, Non-Small-Cell Lung - pathology</subject><subject>Care and treatment</subject><subject>Case-Control Studies</subject><subject>Cell Biology</subject><subject>CpG Islands</subject><subject>DNA</subject><subject>DNA Methylation</subject><subject>DNA, Neoplasm - blood</subject><subject>DNA, Neoplasm - genetics</subject><subject>Epigenesis, Genetic</subject><subject>Epigenetic inheritance</subject><subject>Female</subject><subject>Genes</subject><subject>Genetic aspects</subject><subject>Humans</subject><subject>Internal Medicine</subject><subject>Laboratory Medicine</subject><subject>Lung cancer</subject><subject>Lung Neoplasms - blood</subject><subject>Lung Neoplasms - diagnosis</subject><subject>Lung Neoplasms - genetics</subject><subject>Lung Neoplasms - pathology</subject><subject>Male</subject><subject>Methylation</subject><subject>Middle Aged</subject><subject>Pathology</subject><subject>Protein binding</subject><subject>Receptors, Retinoic Acid - blood</subject><subject>Receptors, Retinoic Acid - genetics</subject><subject>Sulfites</subject><subject>Sulfites - chemistry</subject><issn>0007-4888</issn><issn>1573-8221</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kd9qFDEYxYNY7Fp9AG8kIIg3U5NM_sxcjqvWwlZhUbwM2cw3u1OySU1mLnYfywfxmcwwbWlBJBfhO_mdA_kOQq8oOaeEqPeJEkFVQSgvmCS8OD5BCypUWVSM0adoQTJU8KqqTtHzlK6nkUj6DJ0yQXNALRfo59XlusGNN-6Q-oRDh9fN-s9vhi_AA76CYXdwZuiDx73HH782eNlHO06S307SsAP8wYXQTsNqzOLSeAvxBTrpjEvw8vY-Qz8-f_q-_FKsvl1cLptVYTlTx0KR0rSibkWrZC2VZaqUYGnFOQjSlZ2sqTK2NvWG2FJ13CjJoOwIERtCAWR5ht7NuTcx_BohDXrfJwvOGQ9hTJoKwbmsWc0z-mZGt8aB7n0XhmjshOumrGTejpQsU-f_oPJpYd_b4KHrs_7I8PaBYQfGDbsU3DgtLT0G6QzaGFKK0Omb2O9NPGhK9NSnnvvUuU899amP2fP69nvjZg_tveOuwAywGUj5yW8h6uswxlxn-k_qX71JpsA</recordid><startdate>20140801</startdate><enddate>20140801</enddate><creator>Kapitskaya, K. Yu</creator><creator>Azhikina, T. L.</creator><creator>Ponomaryova, A. A.</creator><creator>Cherdyntseva, N. V.</creator><creator>Vlasov, V. V.</creator><creator>Laktionov, P. P.</creator><creator>Rykova, E. Yu</creator><general>Springer US</general><general>Springer</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20140801</creationdate><title>MIRA Analysis of RARβ2 Gene Methylation in DNA Circulating in the Blood in Lung Cancer</title><author>Kapitskaya, K. Yu ; Azhikina, T. L. ; Ponomaryova, A. A. ; Cherdyntseva, N. V. ; Vlasov, V. V. ; Laktionov, P. P. ; Rykova, E. Yu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c427z-703ad59d5d76967c2736ec1844e50f3f6917ac9a9b0c37f4a762e3f005b01ee63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Aged</topic><topic>Biological Assay</topic><topic>Biomarkers, Tumor - blood</topic><topic>Biomarkers, Tumor - genetics</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Cancer</topic><topic>Carcinoma, Non-Small-Cell Lung - blood</topic><topic>Carcinoma, Non-Small-Cell Lung - diagnosis</topic><topic>Carcinoma, Non-Small-Cell Lung - genetics</topic><topic>Carcinoma, Non-Small-Cell Lung - pathology</topic><topic>Care and treatment</topic><topic>Case-Control Studies</topic><topic>Cell Biology</topic><topic>CpG Islands</topic><topic>DNA</topic><topic>DNA Methylation</topic><topic>DNA, Neoplasm - blood</topic><topic>DNA, Neoplasm - genetics</topic><topic>Epigenesis, Genetic</topic><topic>Epigenetic inheritance</topic><topic>Female</topic><topic>Genes</topic><topic>Genetic aspects</topic><topic>Humans</topic><topic>Internal Medicine</topic><topic>Laboratory Medicine</topic><topic>Lung cancer</topic><topic>Lung Neoplasms - blood</topic><topic>Lung Neoplasms - diagnosis</topic><topic>Lung Neoplasms - genetics</topic><topic>Lung Neoplasms - pathology</topic><topic>Male</topic><topic>Methylation</topic><topic>Middle Aged</topic><topic>Pathology</topic><topic>Protein binding</topic><topic>Receptors, Retinoic Acid - blood</topic><topic>Receptors, Retinoic Acid - genetics</topic><topic>Sulfites</topic><topic>Sulfites - chemistry</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kapitskaya, K. Yu</creatorcontrib><creatorcontrib>Azhikina, T. L.</creatorcontrib><creatorcontrib>Ponomaryova, A. A.</creatorcontrib><creatorcontrib>Cherdyntseva, N. V.</creatorcontrib><creatorcontrib>Vlasov, V. V.</creatorcontrib><creatorcontrib>Laktionov, P. P.</creatorcontrib><creatorcontrib>Rykova, E. Yu</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Bulletin of experimental biology and medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kapitskaya, K. Yu</au><au>Azhikina, T. L.</au><au>Ponomaryova, A. A.</au><au>Cherdyntseva, N. V.</au><au>Vlasov, V. V.</au><au>Laktionov, P. P.</au><au>Rykova, E. Yu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>MIRA Analysis of RARβ2 Gene Methylation in DNA Circulating in the Blood in Lung Cancer</atitle><jtitle>Bulletin of experimental biology and medicine</jtitle><stitle>Bull Exp Biol Med</stitle><addtitle>Bull Exp Biol Med</addtitle><date>2014-08-01</date><risdate>2014</risdate><volume>157</volume><issue>4</issue><spage>516</spage><epage>519</epage><pages>516-519</pages><issn>0007-4888</issn><eissn>1573-8221</eissn><abstract>Analysis of DNA epigenetic mutations in the blood circulating DNA is a prospective trend for creation of noninvasive methods for the diagnosis and treatment effi ciency monitoring in cancer. The methylation status of target genes in circulating DNA was evaluated by methods based on preliminary bisulfi te conversion of DNA. We used a different approach based on selection of hypermethylated sequences of circulating DNA by means of DNA-methyl-binding protein (methylated CpG island recovery assay, MIRA). Methylation was evaluated for RARβ2 tumor suppression gene in circulating DNA in lung cancer and a trend was detected to higher methylation of this gene in the patients in comparison with healthy donors.</abstract><cop>Boston</cop><pub>Springer US</pub><pmid>25110096</pmid><doi>10.1007/s10517-014-2604-z</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0007-4888
ispartof Bulletin of experimental biology and medicine, 2014-08, Vol.157 (4), p.516-519
issn 0007-4888
1573-8221
language eng
recordid cdi_proquest_miscellaneous_1554469294
source MEDLINE; SpringerLink Journals - AutoHoldings
subjects Aged
Biological Assay
Biomarkers, Tumor - blood
Biomarkers, Tumor - genetics
Biomedical and Life Sciences
Biomedicine
Cancer
Carcinoma, Non-Small-Cell Lung - blood
Carcinoma, Non-Small-Cell Lung - diagnosis
Carcinoma, Non-Small-Cell Lung - genetics
Carcinoma, Non-Small-Cell Lung - pathology
Care and treatment
Case-Control Studies
Cell Biology
CpG Islands
DNA
DNA Methylation
DNA, Neoplasm - blood
DNA, Neoplasm - genetics
Epigenesis, Genetic
Epigenetic inheritance
Female
Genes
Genetic aspects
Humans
Internal Medicine
Laboratory Medicine
Lung cancer
Lung Neoplasms - blood
Lung Neoplasms - diagnosis
Lung Neoplasms - genetics
Lung Neoplasms - pathology
Male
Methylation
Middle Aged
Pathology
Protein binding
Receptors, Retinoic Acid - blood
Receptors, Retinoic Acid - genetics
Sulfites
Sulfites - chemistry
title MIRA Analysis of RARβ2 Gene Methylation in DNA Circulating in the Blood in Lung Cancer
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T13%3A21%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=MIRA%20Analysis%20of%20RAR%CE%B22%20Gene%20Methylation%20in%20DNA%20Circulating%20in%20the%20Blood%20in%20Lung%20Cancer&rft.jtitle=Bulletin%20of%20experimental%20biology%20and%20medicine&rft.au=Kapitskaya,%20K.%20Yu&rft.date=2014-08-01&rft.volume=157&rft.issue=4&rft.spage=516&rft.epage=519&rft.pages=516-519&rft.issn=0007-4888&rft.eissn=1573-8221&rft_id=info:doi/10.1007/s10517-014-2604-z&rft_dat=%3Cgale_proqu%3EA386000662%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1554469294&rft_id=info:pmid/25110096&rft_galeid=A386000662&rfr_iscdi=true